ARCHIVES

Orphan Designation Granted To Advaxis HPV Immunotherapy

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Director Challenges Scientists To Develop Molecular “Fingerprints” Of Tumors

December 4, 1998

Animal Problems May Stop NIC Construction Grant To city Of Hope

September 13, 1985

Joe Gray Moves To OHSU Knight Cancer Institute

January 21, 2011

Gleevec To Prevent Recurrence Of Gastrointestinal Cancer

December 26, 2008

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003

Cancer Support Community Reports on Patient Experiences

October 24, 2014